TY - JOUR
T1 - Comparing abilities of different lipid measures in diagnosis of insulin resistance
T2 - A survey of risk factors of non-communicable diseases (SuRFNCD-2007) study
AU - Esteghamati, Alireza
AU - Zandieh, Ali
AU - Zandieh, Basira
AU - Khalilzadeh, Omid
AU - Esteghamati, Sadaf
AU - Meysamie, Alipasha
AU - Nakhjavani, Manouchehr
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2012/2/1
Y1 - 2012/2/1
N2 - Background: Dyslipidemia is a distinguishing characteristic of subjects with insulin resistance. Our aim was to determine the predictive abilities and appropriate cutoffs of different lipid variables for insulin resistance. Methods: We used the data of the individuals without history of known diabetes mellitus, aged 25-64 years, from the third national Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). Fasting blood was collected for lipids, glucose and insulin. Receiver operating characteristics (ROC) curves were used to evaluate the predictive abilities of lipid measures for insulin resistance reflected by a homeostasis model assessment value >1.775. The optimal cutoffs of the selected measures were determined using the maximum Youden index and the point closest to (0,1) on the ROC curve, and were compared with metabolic syndrome definitions to diagnose hyperinsulinemia (fasting insulin ≥10 in men and ≥11 U/L in women). Results: Among lipid measures, low-density lipoprotein cholesterol (LDL-C) was the most tenuously related parameter to insulin resistance. On the contrary, triglycerides and triglycerides to high-density lipoprotein cholesterol ratio (triglycerides/HDL- C) had the highest abilities to determine insulin resistance, regardless of sex and body mass index (BMI). The optimal triglycerides and triglycerides/HDL-C cutoffs were 145 mg/dL and 3.75 for men and 109 mg/dL and 3.00 for women, respectively, which had similar abilities to metabolic syndrome definitions in identifying hyperinsulinemia. Conclusion: Among lipid measures, triglycerides and the triglycerides/HDL-C ratio have the highest predictive abilities for insulin resistance, and the diagnostic values of their appropriate cutoffs are similar to those of metabolic syndrome definitions.
AB - Background: Dyslipidemia is a distinguishing characteristic of subjects with insulin resistance. Our aim was to determine the predictive abilities and appropriate cutoffs of different lipid variables for insulin resistance. Methods: We used the data of the individuals without history of known diabetes mellitus, aged 25-64 years, from the third national Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). Fasting blood was collected for lipids, glucose and insulin. Receiver operating characteristics (ROC) curves were used to evaluate the predictive abilities of lipid measures for insulin resistance reflected by a homeostasis model assessment value >1.775. The optimal cutoffs of the selected measures were determined using the maximum Youden index and the point closest to (0,1) on the ROC curve, and were compared with metabolic syndrome definitions to diagnose hyperinsulinemia (fasting insulin ≥10 in men and ≥11 U/L in women). Results: Among lipid measures, low-density lipoprotein cholesterol (LDL-C) was the most tenuously related parameter to insulin resistance. On the contrary, triglycerides and triglycerides to high-density lipoprotein cholesterol ratio (triglycerides/HDL- C) had the highest abilities to determine insulin resistance, regardless of sex and body mass index (BMI). The optimal triglycerides and triglycerides/HDL-C cutoffs were 145 mg/dL and 3.75 for men and 109 mg/dL and 3.00 for women, respectively, which had similar abilities to metabolic syndrome definitions in identifying hyperinsulinemia. Conclusion: Among lipid measures, triglycerides and the triglycerides/HDL-C ratio have the highest predictive abilities for insulin resistance, and the diagnostic values of their appropriate cutoffs are similar to those of metabolic syndrome definitions.
UR - http://www.scopus.com/inward/record.url?scp=84856055488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856055488&partnerID=8YFLogxK
U2 - 10.1089/met.2011.0002
DO - 10.1089/met.2011.0002
M3 - Review article
C2 - 22010642
AN - SCOPUS:84856055488
VL - 10
SP - 63
EP - 69
JO - Metabolic Syndrome and Related Disorders
JF - Metabolic Syndrome and Related Disorders
SN - 1540-4196
IS - 1
ER -